Real-time enrollment status for this heart failure with reduced ejection fraction clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:06 PM UTC
| NCT Number | NCT07465653 |
| Recruiting Status | Recruiting |
| Condition | Heart Failure With Reduced Ejection Fraction |
| Phase | Clinical Trial |
| Target Enrollment | 12 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 8, 2026 (5 days ago) |
As of July 13, 2026: Clinical trial NCT07465653 is currently recruiting participants. This clinical trial study for heart failure with reduced ejection fraction is actively seeking new participants at 3 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07465653 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07465653 was last updated 5 days ago (July 8, 2026). HelloStudys verifies this status automatically.